UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013019
Receipt number R000015187
Scientific Title Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301)
Date of disclosure of the study information 2014/01/30
Last modified on 2020/08/05 13:54:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301)

Acronym

Phase 2 study of alternate-day administrations of S-1 in elderly patients with gastric cancer (KDOG 1301)

Scientific Title

Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301)

Scientific Title:Acronym

Phase 2 study of alternate-day administrations of S-1 in elderly patients with gastric cancer (KDOG 1301)

Region

Japan


Condition

Condition

Advanced or recurrent gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

efficacy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

response rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

S-1

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

76 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Unresectable advanced or recurrent gastric carcinoma which was confirmed histologically
2. negative or non-measurement of HER2
3. Patient with the measurable lesion
4. 76 years or older
5. ECOG performance status: 0-2
6. Chemo-naive patient
7. Sufficient organ functions in laboratory data within 14 days before enrollment
8. Possible of oral ingestion
9. Written informed consent

Key exclusion criteria

1. History of hypersensitivity for S-1 or ingredients of S-1
2. Patient who takes flucytosine, or phenytoin
3. Severe bone marrow suppression, severe renal dysfunction, or severe liver dysfunction
4. Severe concomitant disease (congestive heart failure, hemorrhagic peptic ulcer, ileus, symptomatic ischemic heart disease, liver cirrhosis, interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema or etc)
5. Patient who suffered from myocardial infarction or cerebral infarction within six months
6. symptomatic brain metastasis
7. Severe mental disorders
8. Active synchronous malignancy
9. Watery diarrhea
10. HBV carrier who has to take nucleotide analogues (e.g. Entecavir) during chemotherapy
11. Patient who is judged inappropriate for the entry into this study by the investigator

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Wasaburo
Middle name
Last name Koizumi

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

2520374

Address

1-15-1, Kitazato, Minami-ku, Sagamihara, Kanagawa, 252-0380 Japan

TEL

042-778-8111

Email

koizumi@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Ishido

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0374

Address

1-15-1, Kitazato, Minami-ku, Sagamihara, Kanagawa, 252-0380 Japan

TEL

042-778-8111

Homepage URL


Email

k.ishido@kitasato-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology, Kitasato University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology, Kitasato University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University School of Medicine Hospital Ethic Comittee

Address

1-15-1, Kitazato, Minami-ku, Sagamihara, Kanagawa, 252-0380 Japan

Tel

042-778-9111

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 30 Day


Related information

URL releasing protocol

none

Publication of results

Published


Result

URL related to results and publications

clinical trial discontinued

Number of participants that the trial has enrolled

6

Results

Clinical trial discontinued due to sluggish accumulation of 6 registered cases

Results date posted

2020 Year 08 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Clinical trial discontinued due to sluggish accumulation of 6 registered cases

Participant flow

Clinical trial discontinued due to sluggish accumulation of 6 registered cases

Adverse events

none

Outcome measures

Clinical trial discontinued due to sluggish accumulation of 6 registered cases

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 01 Month 21 Day

Date of IRB

2014 Year 01 Month 21 Day

Anticipated trial start date

2014 Year 01 Month 30 Day

Last follow-up date

2018 Year 01 Month 30 Day

Date of closure to data entry

2018 Year 01 Month 30 Day

Date trial data considered complete

2018 Year 01 Month 30 Day

Date analysis concluded

2018 Year 01 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 01 Month 30 Day

Last modified on

2020 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015187


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name